Unknown

Dataset Information

0

Fasting Enhances the Contrast of Bone Metastatic Lesions in 18F-Fluciclovine-PET: Preclinical Study Using a Rat Model of Mixed Osteolytic/Osteoblastic Bone Metastases.


ABSTRACT: 18F-fluciclovine (trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid) is an amino acid positron emission tomography (PET) tracer used for cancer staging (e.g., prostate and breast). Patients scheduled to undergo amino acid-PET are usually required to fast before PET tracer administration. However, there have been no reports addressing whether fasting improves fluciclovine-PET imaging. In this study, the authors investigated the influence of fasting on fluciclovine-PET using triple-tracer autoradiography with 14C-fluciclovine, [5,6-³H]-2-fluoro-2-deoxy-d-glucose (³H-FDG), and 99mTc-hydroxymethylene diphosphonate (99mTc-HMDP) in a rat breast cancer model of mixed osteolytic/osteoblastic bone metastases in which the animals fasted overnight. Lesion accumulation of each tracer was evaluated using the target-to-background (muscle) ratio. The mean ratios of 14C-fluciclovine in osteolytic lesions were 4.6 ± 0.8 and 2.8 ± 0.6, respectively, with and without fasting, while those for ³H-FDG were 6.9 ± 2.5 and 5.1 ± 2.0, respectively. In the peri-tumor bone formation regions (osteoblastic), where 99mTc-HMDP accumulated, the ratios of 14C-fluciclovine were 4.3 ± 1.4 and 2.4 ± 0.7, respectively, and those of ³H-FDG were 6.2 ± 3.8 and 3.3 ± 2.2, respectively, with and without fasting. These results suggest that fasting before 18F-fluciclovine-PET improves the contrast between osteolytic and osteoblastic bone metastatic lesions and background, as well as 18F-FDG-PET.

SUBMITTER: Oka S 

PROVIDER: S-EPMC5454847 | biostudies-other | 2017 Apr

REPOSITORIES: biostudies-other

altmetric image

Publications

Fasting Enhances the Contrast of Bone Metastatic Lesions in <sup>18</sup>F-Fluciclovine-PET: Preclinical Study Using a Rat Model of Mixed Osteolytic/Osteoblastic Bone Metastases.

Oka Shuntaro S   Kanagawa Masaru M   Doi Yoshihiro Y   Schuster David M DM   Goodman Mark M MM   Yoshimura Hirokatsu H  

International journal of molecular sciences 20170429 5


<sup>18</sup>F-fluciclovine (<i>trans</i>-1-amino-3-<sup>18</sup>F-fluorocyclobutanecarboxylic acid) is an amino acid positron emission tomography (PET) tracer used for cancer staging (e.g., prostate and breast). Patients scheduled to undergo amino acid-PET are usually required to fast before PET tracer administration. However, there have been no reports addressing whether fasting improves fluciclovine-PET imaging. In this study, the authors investigated the influence of fasting on fluciclovine-  ...[more]

Similar Datasets

| S-EPMC4214278 | biostudies-literature
2013-05-03 | E-GEOD-41619 | biostudies-arrayexpress
2013-05-03 | GSE41619 | GEO
| S-EPMC2836828 | biostudies-literature
| S-EPMC5549491 | biostudies-other
| S-EPMC9237076 | biostudies-literature